AGP Picks
View all

Get your fresh news on health and wellness in New Hampshire

Provided by AGP

New Hampshire Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.

Press releases published on May 7, 2026

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2026
ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals
Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury
Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline
Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings
Krystal Biotech to Present at BofA Securities 2026 Health Care Conference
Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026
vTv Therapeutics to Participate in Upcoming May Investor Conferences
MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights
MediWound to Report First Quarter 2026 Financial Results
Stryker declares an $0.88 per share quarterly dividend
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results
ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates
ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression
Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call
UroGen Pharma to Present at Upcoming Investor Conferences

Share us

on your social networks:

Sign up for:

New Hampshire Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.